BioLineRx Ltd. (BLRX.TA)
ILA 5.8
(-9.38%)
ILA 5.8
(-9.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -22.6 Million | -26.24 Million | -23.57 Million | -23.2 Million | -22.66 Million | -24.19 Million |
| Net Income | -60.61 Million | -24.95 Million | -27.05 Million | -30.02 Million | -25.44 Million | -22.96 Million |
| Depreciation & Amortization | 1.38 Million | 654 Thousand | 703 Thousand | 934 Thousand | 940 Thousand | 545 Thousand |
| Deferred income taxes | 17.93 Million | - | 1.78 Million | 5.65 Million | -4.17 Million | -2.07 Million |
| Stock-based compensation | 2.32 Million | 2.24 Million | 1.49 Million | 1.27 Million | 1.75 Million | 2.52 Million |
| Change in working capital | 15.19 Million | 1.23 Million | -540 Thousand | -1.28 Million | 4.32 Million | -1.7 Million |
| Other non-cash items | 1.16 Million | -5.42 Million | 39 Thousand | 242 Thousand | -72 Thousand | -517 Thousand |
| Investing Cash Flow | 1.44 Million | 4 Million | -38.22 Million | 16.66 Million | 5.25 Million | 9.55 Million |
| Investments in PPE | -297 Thousand | -316 Thousand | -97 Thousand | - | -73 Thousand | -10.21 Million |
| Acquisitions | 181 Thousand | -4137.00 | 38.12 Thousand | - | 6000.00 | 1.5 Million |
| Investment purchases | -47.58 Million | -44 Million | -78 Million | -33.5 Million | -43.54 Million | -26.5 Million |
| Sales/Maturities of investments | 49.32 Million | 48.32 Million | 39.87 Million | 50.16 Million | 48.87 Million | 44.77 Million |
| Other Investing Activities | -181 Thousand | 4137.00 | -38.12 Thousand | 16.66 Million | -6000.00 | 9.72 Million |
| Financing Cash Flow | 15.05 Million | 20.43 Million | 57.74 Million | 17.86 Million | 19.19 Million | 13.09 Million |
| Debt repayment | -1.98 Million | -3.05 Million | -3.57 Million | -3.35 Million | -1.1 Million | -411 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 14.08 Million | 14.35 Million | 50.4 Million | 21.21 Million | 20.29 Million | 3.83 Million |
| Other Financing Activities | 17.04 Million | 9.13 Million | 10.91 Million | 8000.00 | 1000.00 | 9.67 Million |
| Accounts receivables | -358 Thousand | - | - | - | - | - |
| Accounts payables | 4.55 Million | - | - | - | - | - |
| Inventory | -1.95 Million | - | - | - | - | - |
| Other working capital | 12.95 Million | 1.23 Million | -540 Thousand | -1.28 Million | 4.32 Million | -934 Thousand |
| Cash at beginning of period | 10.58 Million | 12.99 Million | 16.83 Million | 5.29 Million | 3.4 Million | 5.11 Million |
| Cash at end of period | 4.25 Million | 10.58 Million | 12.99 Million | 16.83 Million | 5.29 Million | 3.4 Million |
| Capital Expenditure | -297 Thousand | -316 Thousand | -97 Thousand | - | -73 Thousand | -10.21 Million |
| Effect of forex changes on cash | -224 Thousand | -607 Thousand | 207 Thousand | 206 Thousand | 108 Thousand | -166 Thousand |
| Net cash flow / Change in cash | -6.33 Million | -2.4 Million | -3.84 Million | 11.53 Million | 1.89 Million | -1.7 Million |
| Free Cash Flow | -22.9 Million | -26.55 Million | -23.67 Million | -23.2 Million | -22.73 Million | -34.4 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 484 Thousand | -696 Thousand | -13.88 Million | -60.61 Million | -16.02 Million | -18.54 Million |
| Depreciation & Amortization | 476 Thousand | 897 Thousand | 706 Thousand | 1.38 Million | 221 Thousand | 198 Thousand |
| Deferred income taxes | - | - | 3.67 Million | 17.93 Million | 3.15 Million | 7.97 Million |
| Stock-based compensation | 437 Thousand | 533 Thousand | 929 Thousand | 2.32 Million | 472 Thousand | 485 Thousand |
| Change in working capital | -7.2 Million | -10.77 Million | 14.7 Million | 15.19 Million | 1.16 Million | -948 Thousand |
| Other non-cash items | 2.39 Million | 447 Thousand | -1.14 Million | 1.16 Million | 1.11 Million | 1.15 Million |
| Investing Cash Flow | -8.64 Million | 16.68 Million | -20.39 Million | 1.44 Million | 4.09 Million | 11.1 Million |
| Investments in PPE | -27 Thousand | -32 Thousand | -18 Thousand | -297 Thousand | -27 Thousand | -123 Thousand |
| Acquisitions | - | - | 2000.00 | 181 Thousand | 26 Thousand | 56 Thousand |
| Investment purchases | -20.55 Million | - | -33.7 Million | -47.58 Million | -7.87 Million | -506 Thousand |
| Sales/Maturities of investments | 11.94 Million | 16.71 Million | 13.32 Million | 49.32 Million | 12 Million | 11.72 Million |
| Other Investing Activities | -8.61 Million | 16.71 Million | -2000.00 | -181 Thousand | -26 Thousand | -56 Thousand |
| Financing Cash Flow | 23.87 Million | -894 Thousand | 11.74 Million | 15.05 Million | 3.49 Million | -134 Thousand |
| Debt repayment | -18.31 Million | -894 Thousand | -863 Thousand | -1.98 Million | -942 Thousand | -134 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 12.19 Million | 14.08 Million | 1.89 Million | - |
| Other Financing Activities | 24.78 Million | - | 12.6 Million | 17.04 Million | 2.54 Million | -134.00 |
| Accounts receivables | -347 Thousand | -2.47 Million | -358 Thousand | -358 Thousand | - | - |
| Accounts payables | - | - | 358 Thousand | 4.55 Million | - | - |
| Inventory | -745 Thousand | -936 Thousand | -601 Thousand | -1.95 Million | -1.35 Million | - |
| Other working capital | -3.55 Million | -3.93 Million | 15.3 Million | 12.95 Million | 2.52 Million | -948 Thousand |
| Cash at beginning of period | 5.99 Million | 4.25 Million | 7.72 Million | 10.58 Million | 10.1 Million | 9.06 Million |
| Cash at end of period | 9.62 Million | 5.99 Million | 4.25 Million | 4.25 Million | 7.72 Million | 10.1 Million |
| Capital Expenditure | -27 Thousand | -32 Thousand | -18 Thousand | -297 Thousand | -27 Thousand | -123 Thousand |
| Effect of forex changes on cash | -272 Thousand | 51 Thousand | 192 Thousand | -224 Thousand | -72 Thousand | -246 Thousand |
| Net cash flow / Change in cash | 3.63 Million | 1.73 Million | -3.47 Million | -6.33 Million | -2.37 Million | 1.03 Million |
| Free Cash Flow | -11.35 Million | -14.14 Million | 4.97 Million | -22.9 Million | -9.92 Million | -9.8 Million |
IMCR
3025
LEV
ANLT
GMN
002880